Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Assess top-performing Hyd etfs for retirees, comparing yields, risk, and track records to help you choose a fund aligned with retirement goals.
27,416 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Bitcoin price stalls near key levels as Ethereum and Solana lead a broad crypto bounce. Markets await a clear catalys...
When a well-known TV host shares an aggressive cancer diagnosis, it highlights the financial realities many face afte...
Bitcoin moved in a wide range this week as hawkish policy signals and geopolitical uncertainty weighed on risk assets...
Oil sits near $79 per barrel on June 22, 2026, after a sharp intraday swing. The piece explains how the current price...
Oil trades near the mid-$70s on June 24, 2026, as supply concerns and demand signals shape the price outlook for cons...
The S&P 500 closed near a decisive support level, raising the specter of additional losses if buyers fail to defend. ...
A weekend heat wave has buckled the Autobahn near Berlin and halted long-distance trains, upending travel plans and r...
A mid-year luxury market report shows AI-generated fortunes fueling a luxury buyers shift wealth, driving demand for ...
June data show manufacturing activity extended its six-month expansion, signaling resilience amid tariffs and inflati...
Investors are turning away from Hewlett Packard Enterprise as a dividend-rich tech giant with a clearer AI roadmap ga...
Higharc AI has closed a $95 million Series C, backed by USLBM, to accelerate AI-enabled homebuilding. The move aims t...